Medtronic

Medtronic reported total emissions of approximately 5.518 billion kg CO2e in 2025. This includes about 174 million kg CO2e from Scope 1, 79 million kg CO2e from Scope 2, and 5.265 billion kg CO2e from Scope 3 emissions. In 2024, Medtronic disclosed only Scope 3 emissions, which amounted to 866 million kg CO2e. In 2023, the company's Scope 1 emissions were about 131.5 million kg CO2e, and Scope 2 emissions were approximately 125.2 million kg CO2e. Looking back to 2020, Scope 1 emissions were approximately 156 million kg CO2e, and Scope 2 emissions were about 233 million kg CO2e.

Medtronic has set ambitious climate commitments. The company aims to be carbon neutral in its operations by fiscal year 2030 and has an aggressive target to reduce greenhouse gas emissions by 50% by fiscal year 2025. Medtronic PLC, as validated by the Science Based Targets initiative (SBTi), commits to reduce absolute Scope 1 and 2 GHG emissions by 52% by fiscal year 2030 from a fiscal year 2020 base year. Additionally, Medtronic PLC aims to increase active annual sourcing of renewable electricity from 1.29% in fiscal year 2020 to 100% by fiscal year 2030. Furthermore, the company commits that 75% of its suppliers, by emissions covering purchased goods and services and capital goods, will have science-based targets by fiscal year 2030. Medtronic PLC also commits to reduce absolute Scope 3 GHG emissions from upstream transportation and distribution, business travel, and end-of-life treatment of sold products by 37.5% by fiscal year 2034 from a fiscal year 2024 base year. Medtronic PLC has committed to achieving Net-Zero emissions.